(UPI) – A group of scientists, primarily from South Korean universities, has confirmed the efficacy of an oral anti-viral treatment, called CP-COV03 or Xafty, against COVID-19 after a clinical trial.

If a later-stage trial is successful and the medication is approved by the Ministry of Food and Drug Safety, the drug could be available next year. (Read More)